Research
Hormonal
Ethnicity-specific BMI cut-offs are required for accurate diagnosis and management of obesity-related risks, particularly for South Asian populations.
If you are of South Asian descent, be aware that your risk for Type 2 Diabetes increases at a lower BMI (around 23.9 kg/m2) compared to the standard 30 kg/m2. Discuss ethnicity-specific risk assessments with your healthcare provider.
GoodQualifiesHIGH confidence
In a recent population-based cohort study based on >1.47M people living in England, it was demonstrated that for the equivalent age- and sex-adjusted incidence of T2D at a BMI of 30 kg/m2 in white populations, the BMI cut-off in south Asian populations was 23.9 kg/m2.
Why this rating
Based on a large population-based cohort study (Ref 13).
Source
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?
Thomas M. Barber · HepatoBiliary Surgery and Nutrition · 2023
DOI 10.21037/hbsn-23-143
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- The updated CG189 NICE guidelines recommend self-measurement of waist-to-height ratio (target ≥0.5) for adults with BMI <35 kg/m2 to assess abdominal fat and health risk, shifting focus from BMI alone.Good
- Societal stigma surrounding obesity negatively impacts psychological, physical, and socioeconomic health, and hinders engagement with obesity services.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →